ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
Clinical trial NCT03587740 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03587740
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2025-03-03
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.